PMID: 23439096DOI: 10.1016/s0140-6736(13)60342-6Feb 27, 2013

Resistance to second-line drugs in multidrug-resistant tuberculosis

Lancet
Zarir F Udwadia

Abstract

No abstract listed.

References

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

Sep 4, 2012·Lancet·Tracy L DaltonPiret Viiklepp

Citations

In vitro and intracellular activity of 4-substituted piperazinyl phenyl oxazolidinone analogues against Mycobacterium tuberculosis

Feb 15, 2014·The Journal of Antimicrobial Chemotherapy·Di WangPing Gong

Fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis independent of fluoroquinolone use

Dec 9, 2017·The European Respiratory Journal·Yang CheMei Yu

Barriers to new drug development in respiratory disease

Jan 2, 2016·The European Respiratory Journal·Grania BrigdenSidney Wong

Related Concepts

Antitubercular Agents
Tuberculosis, Drug-Resistant
Tuberculosis, Multidrug-Resistant
Pharmacologic Substance

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Nomenclature of drug-resistant tuberculosis

(opens in new tab)
The Lancet Infectious Diseases
Zarir F UdwadiaCamilla S Rodrigues
ContactHelpTerms Privacy Cookies Blog
© 2021 Meta ULC. All rights reserved